In an early clinical trial, a single dose of a short-acting psychedelic drug led to rapid improvement in people with major depressive disorder.
The study included 34 patients with moderate-to-severe depression, all of whom had tried other…
Continue Reading
News Source: www.sciencealert.com

Leave a Reply